These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 12409266)
41. Left ventricular noncompaction cardiomyopathy and short QT syndrome due to primary carnitine deficiency. Hanington OP; Armstrong C; Pierre G; Stuart G; Hancox JC Ann Noninvasive Electrocardiol; 2023 Nov; 28(6):e13077. PubMed ID: 37658577 [TBL] [Abstract][Full Text] [Related]
42. Identification and tissue distribution of two differentially spliced variants of the rat carnitine transporter OCTN2. Brooks H; Krähenbühl S FEBS Lett; 2001 Nov; 508(2):175-80. PubMed ID: 11718711 [TBL] [Abstract][Full Text] [Related]
43. Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children. Pierpont ME; Breningstall GN; Stanley CA; Singh A Am Heart J; 2000 Feb; 139(2 Pt 3):S96-S106. PubMed ID: 10650322 [TBL] [Abstract][Full Text] [Related]
44. Molecular enzymology of carnitine transfer and transport. Ramsay RR; Gandour RD; van der Leij FR Biochim Biophys Acta; 2001 Mar; 1546(1):21-43. PubMed ID: 11257506 [TBL] [Abstract][Full Text] [Related]
45. Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence. Rijlaarsdam RS; van Spronsen FJ; Bink-Boelkens MT; Reijngoud DJ; Wanders RJ; Niezen-Koning KE; Van der Sluijs FH; Dorland B; Beaufort-Krol GC Pacing Clin Electrophysiol; 2004 May; 27(5):675-6. PubMed ID: 15125729 [TBL] [Abstract][Full Text] [Related]
46. Characterization of organic cation/carnitine transporter family in human sperm. Xuan W; Lamhonwah AM; Librach C; Jarvi K; Tein I Biochem Biophys Res Commun; 2003 Jun; 306(1):121-8. PubMed ID: 12788076 [TBL] [Abstract][Full Text] [Related]
47. L-Carnitine transport in mouse renal and intestinal brush-border and basolateral membrane vesicles. Lahjouji K; Malo C; Mitchell GA; Qureshi IA Biochim Biophys Acta; 2002 Jan; 1558(1):82-93. PubMed ID: 11750267 [TBL] [Abstract][Full Text] [Related]
48. Primary carnitine deficiency in the Chinese. Tang NL; Hui J; Law LK; To KF; Cheung KL; Magnus HN; Yuen PM; Fok TF Chin Med J (Engl); 2000 Apr; 113(4):376-80. PubMed ID: 11775240 [No Abstract] [Full Text] [Related]
49. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. Kido Y; Tamai I; Ohnari A; Sai Y; Kagami T; Nezu J; Nikaido H; Hashimoto N; Asano M; Tsuji A J Neurochem; 2001 Dec; 79(5):959-69. PubMed ID: 11739607 [TBL] [Abstract][Full Text] [Related]
50. Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up. Yilmaz BS; Kor D; Mungan NO; Erdem S; Ceylaner S J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1179-81. PubMed ID: 26030785 [TBL] [Abstract][Full Text] [Related]
51. Pharmacological rescue of carnitine transport in primary carnitine deficiency. Amat di San Filippo C; Pasquali M; Longo N Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335 [TBL] [Abstract][Full Text] [Related]
52. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. El-Hattab AW; Li FY; Shen J; Powell BR; Bawle EV; Adams DJ; Wahl E; Kobori JA; Graham B; Scaglia F; Wong LJ Genet Med; 2010 Jan; 12(1):19-24. PubMed ID: 20027113 [TBL] [Abstract][Full Text] [Related]
54. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy. Makhseed N; Vallance HD; Potter M; Waters PJ; Wong LT; Lillquist Y; Pasquali M; Amat di San Filippo C; Longo N J Inherit Metab Dis; 2004; 27(6):778-80. PubMed ID: 15617188 [TBL] [Abstract][Full Text] [Related]
55. Primary carnitine deficiency - diagnosis after heart transplantation: better late than never! Grünert SC; Tucci S; Schumann A; Schwendt M; Gramer G; Hoffmann GF; Erbel M; Stiller B; Spiekerkoetter U Orphanet J Rare Dis; 2020 Apr; 15(1):87. PubMed ID: 32276632 [TBL] [Abstract][Full Text] [Related]
56. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528 [TBL] [Abstract][Full Text] [Related]
57. Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. Karlic H; Lohninger A; Laschan C; Lapin A; Böhmer F; Huemer M; Guthann E; Rappold E; Pfeilstöcker M J Mol Med (Berl); 2003 Jul; 81(7):435-42. PubMed ID: 12802501 [TBL] [Abstract][Full Text] [Related]
59. Functional and molecular studies in primary carnitine deficiency. Frigeni M; Balakrishnan B; Yin X; Calderon FRO; Mao R; Pasquali M; Longo N Hum Mutat; 2017 Dec; 38(12):1684-1699. PubMed ID: 28841266 [TBL] [Abstract][Full Text] [Related]
60. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2. Inano A; Sai Y; Nikaido H; Hasimoto N; Asano M; Tsuji A; Tamai I Biopharm Drug Dispos; 2003 Nov; 24(8):357-65. PubMed ID: 14595704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]